Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-07-001678
Filing Date
2007-02-27
Accepted
2007-02-27 16:26:53
Documents
12
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 c45786_10k.txt 10-K 456575
2 c45786_ex10-55.txt EX-10.55 56000
3 c45786_ex10-56.txt EX-10.56 35003
4 c45786_ex10-57.txt EX-10.57 7070
5 c45786_ex21-1.txt EX-21.1 3054
6 c45786_ex23-1.txt EX-23.1 1684
7 c45786_ex31-1.txt EX-31.1 4007
8 c45786_ex31-2.txt EX-31.2 3971
9 c45786_ex32-1.txt EX-32.1 1326
10 c45786_ex32-2.txt EX-32.2 1366
11 c45786_ex99-1.htm EX-99.1 2512
12 GRAPHIC c45786_ex99-1x1x1.jpg GRAPHIC 26851
  Complete submission text file 0000930413-07-001678.txt   611568
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 0501
Type: 10-K | Act: 34 | File No.: 000-16132 | Film No.: 07653595
SIC: 2834 Pharmaceutical Preparations